Alpha Biopharma
alphabiopharma.comDeveloper of drugs and clinical products designed to address unmet clinical needs.
Last Round
Apr 2022
Series B
Series B · $595.0M
Price per share
12M · USD
Loading chart...
Funding history
$M raised · $B post-money
Loading chart...